Plain-English translation of NCT06346054 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing whether certain molecules in your breath and blood — called oncometabolic biomarkers — can help doctors catch stomach and esophageal cancer in its earliest stages. This is a diagnostic study, meaning it's designed to improve detection methods rather than test a new treatment. By comparing samples from people with cancer, people with Barrett's esophagus (a precancerous condition), and healthy people, researchers hope to identify reliable signs of early cancer that doctors could use in the future.
Early detection of stomach and esophageal cancer can make a huge difference in treatment outcomes. Right now, doctors don't have a simple, noninvasive way to screen for these cancers in people at risk. This study aims to develop a breath and blood test that could catch cancer much earlier, before symptoms appear.
You likely qualify if…
You likely don't qualify if…
Your involvement is straightforward and minimally invasive. During your regular medical visits, you'll be asked to provide a breath sample and a blood sample — both routine procedures. Researchers will analyze these samples to look for the special molecules they're testing. There is no medication to take, and participation fits into your normal healthcare appointments.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Belgium